Back
Pilgrims Pride 10K Form
Sell
44
PPC
Pilgrims Pride
Last Price:
$46.16
Seasonality Move:
13.71%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-02 | 10Q | PPC/Pilgrims Pride Quarterly |
2023-10-26 | 10Q | PPC/Pilgrims Pride Quarterly |
2023-07-27 | 10Q | PPC/Pilgrims Pride Quarterly |
2023-04-27 | 10Q | PPC/Pilgrims Pride Quarterly |
2022-10-27 | 10Q | PPC/Pilgrims Pride Quarterly |
2022-07-28 | 10Q | PPC/Pilgrims Pride Quarterly |
Receive PPC News And Ratings
See the #1 stock for the next 7 days that we like better than PPC
PPC Financial Statistics
Sales & Book Value
Annual Sales: | $17.4B |
---|---|
Cash Flow: | $547.4M |
Price / Cash Flow: | 7.36 |
Annual Sales: | $17.73 |
Price / Book: | 2.6 |
Profitability
EPS (TTM): | 4.14000 |
---|---|
Net Income (TTM): | $985.2M |
Gross Margin: | $1.1B |
Return on Equity: | 27.53% |
Return on Assets: | 9.8% |
Pilgrims Pride Earnings Forecast
Key Pilgrims Pride Financial Ratios
-
The Gross Profit Margin over the past 40 years for PPC is 6.44%.
-
The Selling, General & Administrative Expenses for PPC have been equal to 3.18% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 62.90% of Operating Income.
-
The Net Earning history of PPC is 1.85% of Total Revenues.
-
Per Share Earnings over the last 40 years have been positive in 20 years.
Pilgrims Pride Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Food Products |
Sector: | Consumer Staples |
Current Symbol: | PPC |
CUSIP: | 72147K |
Website: | pilgrims.com |
Debt
Debt-to-Equity Ratio: | 0.76 |
---|---|
Current Ratio: | 1.95 |
Quick Ratio: | 1.17 |
Price-to-Earnings
Trailing P/E Ratio: | 33.94 |
---|---|
Forward P/E Ratio: | 10.5 |
PPC Technical Analysis vs Fundamental Analysis
Sell
44
Pilgrims Pride (PPC)
is a Sell
Is Pilgrims Pride a Buy or a Sell?
-
Pilgrims Pride stock is rated a SellThe current Pilgrims Pride [PPC] share price is $46.16. The Score for PPC is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.